ERC Consolidator Grant · 2021
Disruptive Therapies for the long-term relief of Osteoarthritis Pain
Osteoarthritis (OA) is the most common cause of chronic pain in older persons in Europe and is the leading cause of disability. The disease is a condition affecting the joint cartilage and subchondral bone and is frequently accompanied by pain, stiffness, and long-term disability. Chronic pain is the most prominent symptom in most people with OA, and is the most important determinant of disability in patients with osteoarthritis. Treatment guidelines for OA pain management uniformly recommends a range of pharmacological therapies, including paracetamol, NSAIDs and opioids, together with non-pharmacological therapies. However, such therapies are restricted by considerable side effects and…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.